Multiple Sclerosis study: MBCT
Official title Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice
ClinicalTrials.gov ID: NCT07573241
What this study is testing
- What it's testing
- The study aims to find out which emotional, physical, and environmental factors make it easier or harder to practice mindfulness every day.
- Who it's for
- The study is looking for people who have multiple sclerosis and chronic pain.
- What's involved
- Participants will join a group program for mindfulness-based cognitive therapy and share what makes their daily practice easier or more difficult.
- Time commitment
- The source text does not specify the duration or number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have an MS diagnosis of any subtype per record review
- Average pain intensity in past week of at least moderate severity (\>3 on the 0-10 numerical rating scale)
- Report pain \>50% of days in the past 3 months.
- Are able to comply with study procedures and complete measures independently via self-report (on mobile phone)
You likely can't join if
- Less than 18 years of age
- Score greater than 8 on the Expanded Disability Status Scale
- Have significant cognitive impairment as indicated by 1 or more errors on the 6-item Cognitive Screener
- Change in disease modifying medications in the past 3 months assessed via self-report (although participants will be considered eligible after the...
- History of MS relapse within the last 30 days prior to screening assessed via self-report (although participants will be considered eligible after...
- Current suicidal ideation with intent or plan as indicated by a score of 1 or higher on the Patient Health Questionnaire-9 suicide item and further...
See the full eligibility criteria
- Have an MS diagnosis of any subtype per record review
- Average pain intensity in past week of at least moderate severity (\>3 on the 0-10 numerical rating scale)
- Report pain \>50% of days in the past 3 months.
- Are able to comply with study procedures and complete measures independently via self-report (on mobile phone)
- Less than 18 years of age
- Score greater than 8 on the Expanded Disability Status Scale
- Have significant cognitive impairment as indicated by 1 or more errors on the 6-item Cognitive Screener
- Change in disease modifying medications in the past 3 months assessed via self-report (although participants will be considered eligible after the 3-month window)
- History of MS relapse within the last 30 days prior to screening assessed via self-report (although participants will be considered eligible after the 3-month window)
- Current suicidal ideation with intent or plan as indicated by a score of 1 or higher on the Patient Health Questionnaire-9 suicide item and further assessment with the Columbia-Suicide Severity Rating Scale (although...
- Currently engaged in psychotherapy for pain assessed via self-report
- Currently have a "regular" mindfulness practice defined as \> 3 days per week assessed via self-report
- Inability to read or speak English
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.